Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor

被引:349
作者
Pettersson, A
Nagy, JA
Brown, LF
Sundberg, C
Morgan, E
Jungles, S
Carter, R
Krieger, JE
Manseau, EJ
Harvey, VS
Eckelhoefer, IA
Feng, D
Dvorak, AM
Mulligan, RC
Dvorak, HF [1 ]
机构
[1] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA
[2] Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02215 USA
[3] Harvard Univ, Sch Med, Inst Human Genet, Boston, MA 02215 USA
关键词
D O I
10.1038/labinvest.3780013
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) is an angiogenic cytokine with potential for the treatment of tissue ischemia. To investigate the properties of the new blood vessels induced by VPF/VEGF, we injected an adenoviral vector engineered to express murine VPF/VEGF(154) into several normal tissues of adult nude mice or rats. A dose-dependent angiogenic response was induced in all tissues studied but was more intense and persisted longer (months) in skin and fat than in heart or skeletal muscle (less than or equal to 3 weeks). The initial response (within 18 hours) was identical in all tissues studied and was characterized by microvascular hyperpermeability, edema, deposition of an extravascular fibrin gel, and the formation of enlarged, thin-walled pericyte-poor vessels ("mother" vessels). Mother vessels developed from preexisting microvessels after pericyte detachment and basement membrane degradation. Mother vessels were transient structures that evolved variably in different tissues into smaller daughter vessels, disorganized vessel tangles (glomeruloid bodies), and medium-sized muscular arteries and veins. Vascular structures closely resembling mother vessels and each mother vessel derivative have been observed in benign and malignant tumors, in other examples of pathological and physiological angiogenesis, and in vascular malformations. Together these data suggest that VPF/VEGF has a role in the pathogenesis of these entities. They also indicate that the angiogenic response induced by VPF/VEGF is heterogeneous and tissue specific. Finally, the muscular vessels that developed from mother vessels in skin and perimuscle fat have the structure of collaterals and could be useful clinically in the relief of tissue ischemia.
引用
收藏
页码:99 / 115
页数:17
相关论文
共 77 条
[1]   Vascular bed-specific expression of an endothelial cell gene is programmed by the tissue microenvironment [J].
Aird, WC ;
Edelberg, JM ;
WeilerGuettler, H ;
Simmons, WW ;
Smith, TW ;
Rosenberg, RD .
JOURNAL OF CELL BIOLOGY, 1997, 138 (05) :1117-1124
[2]  
[Anonymous], 1985, CORONARY COLLATERALS
[3]   Isolation of putative progenitor endothelial cells for angiogenesis [J].
Asahara, T ;
Murohara, T ;
Sullivan, A ;
Silver, M ;
vanderZee, R ;
Li, T ;
Witzenbichler, B ;
Schatteman, G ;
Isner, JM .
SCIENCE, 1997, 275 (5302) :964-967
[4]   Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia [J].
Baumgartner, I ;
Pieczek, A ;
Manor, O ;
Blair, R ;
Kearney, M ;
Walsh, K ;
Isner, JM .
CIRCULATION, 1998, 97 (12) :1114-1123
[5]   PHYSIOLOGICAL ASSESSMENT OF AUGMENTED VASCULARITY INDUCED BY VEGF IN ISCHEMIC RABBIT HINDLIMB [J].
BAUTERS, C ;
ASAHARA, T ;
ZHENG, LP ;
TAKESHITA, S ;
BUNTING, S ;
FERRARA, N ;
SYMES, JF ;
ISNER, JM .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1994, 267 (04) :H1263-H1271
[6]   Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance [J].
Boehm, T ;
Folkman, J ;
Browder, T ;
OReilly, MS .
NATURE, 1997, 390 (6658) :404-407
[7]   Genentech enlightens other angiogenesis programs [J].
Brower, V .
NATURE BIOTECHNOLOGY, 1999, 17 (04) :326-327
[8]  
Brown L F, 1997, EXS, V79, P233
[9]   EXPRESSION OF VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) BY EPIDERMAL-KERATINOCYTES DURING WOUND-HEALING [J].
BROWN, LF ;
YEO, KT ;
BERSE, B ;
YEO, TK ;
SENGER, DR ;
DVORAK, HF ;
VANDEWATER, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) :1375-1379
[10]  
Brown LF, 1996, AM J PATHOL, V148, P1065